Fresh analysis suggests that patients who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Published data in a major medical journal demonstrates that while overweight individuals can lose a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such medications need to be informed of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb.
That rate of recovery suggests a return to original weight within about a year and a half.
Comparing Therapies
The study, which looked at dozens of studies involving thousands of participants, contrasted the results of the injectable medications with older methods.
The team note that individuals who lose weight through dieting generally see a more gradual weight regain—around 100 grams monthly—after stopping.
Explaining the Fast Rebound
Nutrition scientists propose the mechanism of the drugs explains the heightened rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Disease?
Health authorities suggest the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, given the likelihood of relapse, the treatment might need to be ongoing.
This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like hypertension.
Patient Testimonies
People who have stopped the medication report a powerful return of appetite.
"It felt as if something that goes on and you're instantly extremely hungry," described a patient.
This challenge is worsened if individuals have not developed lasting dietary or behavioural changes during therapy.
Widespread Adoption
Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is more common among females compared to men.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
Finally, researchers emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent solution and long-term success relies on ongoing lifestyle management.